Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management
S Sukumar, B Lämmle, SR Cataland - Journal of clinical medicine, 2021 - mdpi.com
Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy
characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and …
characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and …
Syndromes of thrombotic microangiopathy
JN George, CM Nester - New England Journal of Medicine, 2014 - Mass Medical Soc
Syndromes of Thrombotic Microangiopathy | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …
content The New England Journal of Medicine homepage Advanced Search SEARCH …
Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura
Background In acquired thrombotic thrombocytopenic purpura (TTP), an immune-mediated
deficiency of the von Willebrand factor–cleaving protease ADAMTS13 allows unrestrained …
deficiency of the von Willebrand factor–cleaving protease ADAMTS13 allows unrestrained …
Caplacizumab for acquired thrombotic thrombocytopenic purpura
Background Acquired thrombotic thrombocytopenic purpura (TTP) is caused by aggregation
of platelets on ultralarge von Willebrand factor multimers. This microvascular thrombosis …
of platelets on ultralarge von Willebrand factor multimers. This microvascular thrombosis …
Thrombotic thrombocytopenic purpura
JA Kremer Hovinga, P Coppo, B Lämmle… - Nature reviews Disease …, 2017 - nature.com
Thrombotic thrombocytopenic purpura (TTP; also known as Moschcowitz disease) is
characterized by the concomitant occurrence of often severe thrombocytopenia …
characterized by the concomitant occurrence of often severe thrombocytopenia …
Thrombotic thrombocytopenic purpura
BS Joly, P Coppo, A Veyradier - Blood, The Journal of the …, 2017 - ashpublications.org
Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic
microangiopathy characterized by microangiopathic hemolytic anemia, severe …
microangiopathy characterized by microangiopathic hemolytic anemia, severe …
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross …
E Mariotte, E Azoulay, L Galicier, E Rondeau… - The Lancet …, 2016 - thelancet.com
Background Thrombotic thrombocytopenic purpura is a thrombotic microangiopathy related
to a severe deficiency of ADAMTS13 (a disintegrin and metalloprotease with …
to a severe deficiency of ADAMTS13 (a disintegrin and metalloprotease with …
Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015
EE Page, JA Kremer Hovinga, DR Terrell… - Blood …, 2017 - ashpublications.org
Our objective was to describe new observations from the Oklahoma Thrombotic
Thrombocytopenic Purpura (TTP) Registry experience (November 1995 through December …
Thrombocytopenic Purpura (TTP) Registry experience (November 1995 through December …
[HTML][HTML] The international hereditary thrombotic thrombocytopenic purpura registry: key findings at enrollment until 2017
HA van Dorland, MM Taleghani, K Sakai… - …, 2019 - ncbi.nlm.nih.gov
Congenital thrombotic thrombocytopenic purpura is an autosomal recessive inherited
disease with a clinically heterogeneous course and an incompletely understood genotype …
disease with a clinically heterogeneous course and an incompletely understood genotype …
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura
M Jestin, Y Benhamou, AS Schelpe… - Blood, The Journal …, 2018 - ashpublications.org
Preemptive rituximab infusions prevent relapses in immune thrombotic thrombocytopenic
purpura (iTTP) by maintaining normal ADAMTS13 activity. However, the long-term outcome …
purpura (iTTP) by maintaining normal ADAMTS13 activity. However, the long-term outcome …